Cite
EP-1419: Optimal design and patient selection for interventional trials using radiogenomic biomarkers
MLA
Catharine M L West, et al. “EP-1419: Optimal Design and Patient Selection for Interventional Trials Using Radiogenomic Biomarkers.” Radiotherapy and Oncology, vol. 123, May 2017, pp. S758–59. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........93a7d37a79612567368022f4a7645838&authtype=sso&custid=ns315887.
APA
Catharine M L West, Bram Ramaekers, Søren M. Bentzen, Timothy H Ward, Hilary Stobart, T. Van Staa, P. Lambin, Sarah L. Kerns, Dirk De Ruysscher, Gilles Defraene, & Erik Briers. (2017). EP-1419: Optimal design and patient selection for interventional trials using radiogenomic biomarkers. Radiotherapy and Oncology, 123, S758–S759.
Chicago
Catharine M L West, Bram Ramaekers, Søren M. Bentzen, Timothy H Ward, Hilary Stobart, T. Van Staa, P. Lambin, et al. 2017. “EP-1419: Optimal Design and Patient Selection for Interventional Trials Using Radiogenomic Biomarkers.” Radiotherapy and Oncology 123 (May): S758–59. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........93a7d37a79612567368022f4a7645838&authtype=sso&custid=ns315887.